Isolation and characterization of cetirizine degradation product: Mechanism of cetirizine oxidation

Pharmaceutical Research

Volumn 27, Issue 7, 2010, Pages 1318-1324

  Dyakonov, Tatyana ^a   Muir, April ^a   Nasri, Hassen ^a   Toops, Dana ^a   Fatmi, Aqeel ^a  

^a Banner Pharmacaps   (United States)

Author keywords

Cetirizine; Oxidation; PEG

Indexed keywords

CETIRIZINE; HYDROGEN PEROXIDE; MACROGOL; HISTAMINE H1 RECEPTOR ANTAGONIST; MACROGOL DERIVATIVE;

ARTICLE; CONTROLLED STUDY; DEALKYLATION; DRUG DEGRADATION; DRUG FORMULATION; DRUG ISOLATION; DRUG MIXTURE; DRUG OXIDATION; DRUG PURIFICATION; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROXYLATION; IONIZATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PH; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; ULTRAVIOLET SPECTROSCOPY; CHEMICAL STRUCTURE; CHEMISTRY; ISOLATION AND PURIFICATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION REDUCTION REACTION;

CETIRIZINE; CHROMATOGRAPHY, LIQUID; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HYDROGEN PEROXIDE; HYDROGEN-ION CONCENTRATION; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MOLECULAR STRUCTURE; OXIDATION-REDUCTION; POLYETHYLENE GLYCOLS;

EID: 77953619074     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-010-0114-x     Document Type: Article

References (12)

1. JW Jones JJ Francis 2000 Softgels: consumer perceptions and market impact relative to other oral dosage forms Adv ther. 17 5 10.1007/BF02853160
2. SN Makhija PR Vavia 2001 Stability indicating HPTLC method for the simultaneous determination of pseudoephedrine and cetirizine in pharmaceutical formulations J Pharm Biomed Anal. 25 663 7 10.1016/S0731-7085(00)00586-0 1:CAS:528:DC%2BD3MXjslelur0%3D 11377047 (Pubitemid 32493923)
3. 14C] levocetirizine, the R enantiomer of cetirizine, in healthy volunteers Eur J Clin Pharmacol. 57 571 82 10.1007/s002280100364 1:STN:280:DC%2BD38%2Fjt1ektQ%3D%3D 11758635 (Pubitemid 33027975)
4. V. Kumar, DS, Kalonia. Removal of Peroxides in Polyethylene Glycols by Vacuum Drying: Implications in the stability of Biotech and Parmaceutical Formulations. AAPS PharSciTech. 7(3) 2006; Article 62. DOI; 10 1208 /pt070362.
5. R Hamburger E Azaz M Donbrow 1975 Autoxidation of polyoxyethylenic nonionic surfactants and of polyethylene glycols Pharm Acta Helv. 50 1-2 10 7 1:CAS:528:DyaE2MXhsVCqsr0%3D 234621
6. M Donbrow E Azaz A Pillersdorf 1978 Autoxidation of polysorbates J Pharm Sci. 67 12 1676 81 10.1002/jps.2600671211 1:CAS:528:DyaE1MXns1CrtQ%3D%3D 31449
7. Shimizu S, Watanabe N, Kuranishi H. US 5, 668281 (1997).
8. A Pagliara B Testa PA Carrupt P Jolliet C Morin D Morin, et al. 1998 Molecular properties and pharmacokinetic behaviour of cetirizine, a zwitterionic H1-receptor antagonist J Med Chem. 41 853 63 10.1021/jm9704311 1:CAS:528:DyaK1cXhtF2mu7w%3D 9526560 (Pubitemid 28146241)
9. AL Freed HE Strohmeyer M Mahjour V Sadineni DL Reid CA Kingsmill 2008 pH control of nucleophilic/electrophilic oxidation Int J Pharm. 357 180 8 10.1016/j.ijpharm.2008.01.061 1:CAS:528:DC%2BD1cXlsFCqurc%3D 18400425
10. KY Tam L Quere 2001 Multiwavelenght spectrophotometric resolution of the micro- equilibria of cetirizine Anal Sci. 17 1203 8 10.2116/analsci.17.1203 1:CAS:528:DC%2BD3MXotVSitrc%3D 11990597 (Pubitemid 33042987)
11. A Salvador J Sousa RE Pinto 2001 Hydroperoxyl Superoxide and pH Gradients in the Mitochondrial Matrix: A Theoretical Assessment Free Radic Biol Med. 31 10 1208 15 10.1016/S0891-5849(01)00707-9 1:CAS:528:DC%2BD3MXot1Olsbs%3D 11705699 (Pubitemid 33052496)
12. Nasri H, Dyakonov T, Toops D. Compatibility of shell ingredients with hydrophilic actives in gelatin-based dosage forms, presented at AAPS, Atlanta (2008).